Submission Number: 560891-00300
Received: 9/10/2012 5:42:25 PM
Commenter: Charles Matheson
Organization: Butler Schein Animal Health
Agency: Federal Trade Commission
Initiative: Request for Comments and Announcement of Workshop on Pet Medications Issues, Project No. P121201
Attachments: No Attachments
My concern is that the veterinarians rely on this income from selling these drugs to offset the cost of office visits, procedures etc. Talking to the doctors about this, there seems to be a conclusion that the customer will be paying much more for any surgery, procedures etc. So there will not be any cost savings to consumers as they will be paying more for services instead of drugs. Not to mention all the people in the industry that could be out of a job if they cant sell medications to the doctor. Also, the pharmacist who sell this medication are not trained on how the product should be used and could wind up hurting the animal. Then they would have to take it back to the vet(since the product was not bought from the vet the customer would have to pay for treatment) for the mistakes of the pharmacist. They are not trained in veterinary medicine. This would hurt the dr patient relationship and I believe this would cost the consumer more than it would save. Also, it is convienient not to have to got to the pharmacy to fill the scribe. Its bad enough as it is with the crowds in pharmacies waiting on their scribe. Having pet owners in the pharmacy getting in the way of people who really need their drugs.